Close Menu

Editas Medicine says that it will be testing CRISPR-based gene editing in people by 2017, according to Technology Review.

At the EmTech conference, CEO Katrine Bosley said the startup — co-founded by the Broad Institute's Feng Zhang — plans to start a clinical trial within two years to test the use of gene editing to treat Leber congenital amaurosis, a rare form of blindness affecting the retina.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers are sampling the wild relatives of modern crops to try to preserve genetic diversity, NPR reports.

MIT's Search for Extraterrestrial Genomes is developing sequencing tools to use to try to detect whether there is any life on Mars, Quartz reports.

Undark reports on a bill introduced this year to the US House of Representatives to strengthen scientific integrity.

In Genome Research this week: post-zygotic mutations in diabetes development, single-cell RNA sequencing study of aging, and more.